(Q34981939)

5 August 2017

1 reference

title

Adenoassociated virus vectors for genetic immunization (English)

1 reference

5 August 2017

0 references

0 references

Selvarangan Ponnazhagan

series ordinal

1

1 reference

5 August 2017

publication date

1 January 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

26

1 reference

5 August 2017

issue

1-3

1 reference

5 August 2017

page(s)

247-253

1 reference

Repeated delivery of adeno-associated virus vectors to the rabbit airway

5 August 2017

cites work

1 reference

12 December 2020

Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle

1 reference

12 December 2020

Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells

1 reference

12 December 2020

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

1 reference

12 December 2020

Adeno-associated virus as a vector for liver-directed gene therapy.

1 reference

12 December 2020

Long-term genetic modification of rhesus monkey hematopoietic cells following transplantation of adenoassociated virus vector-transduced CD34+ cells

1 reference

12 December 2020

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

12 December 2020

Recombinant adeno-associated virus for muscle directed gene therapy

1 reference

12 December 2020

A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease

1 reference

12 December 2020

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

1 reference

12 December 2020

Cloning and characterization of adeno-associated virus type 5.

1 reference

12 December 2020

On the role of antigen in maintaining cytotoxic T-cell memory

1 reference

12 December 2020

Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers

1 reference

12 December 2020

Induction of tolerance to human factor VIII in mice

1 reference

12 December 2020

Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV).

1 reference

12 December 2020

Sustained correction of bleeding disorder in hemophilia B mice by gene therapy

1 reference

12 December 2020

A phase I/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis

1 reference

12 December 2020

Adeno-associated virus-based vectors in gene therapy

1 reference

12 December 2020

Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer

1 reference

12 December 2020

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.

1 reference

12 December 2020

Dose response to a single intramuscular injection of recombinant adeno-associated virus-erythropoietin in monkeys

1 reference

12 December 2020

Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes

1 reference

12 December 2020

Adeno-associated virus for cancer gene therapy.

1 reference

12 December 2020

rAAV vector-mediated sarcogylcan gene transfer in a hamster model for limb girdle muscular dystrophy

1 reference

12 December 2020

Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure

1 reference

12 December 2020

Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart

1 reference

12 December 2020

In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector

1 reference

12 December 2020

Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles.

1 reference

12 December 2020

Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression

1 reference

12 December 2020

Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors

1 reference

12 December 2020

Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells

1 reference

12 December 2020

Detection of adeno-associated virus type 2 in human peripheral blood cells

1 reference

12 December 2020

Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2.

1 reference

12 December 2020

Transduction and utility of the granulocyte-macrophage colony-stimulating factor gene into monocytes and dendritic cells by adeno-associated virus.

1 reference

12 December 2020

Adeno-associated virus-mediated gene delivery

1 reference

12 December 2020

The cryptic life style of adeno-associated virus

1 reference

12 December 2020

Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D

1 reference

12 December 2020

Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo

1 reference

12 December 2020

Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: implications for ex vivo immunotherapy

1 reference

12 December 2020

Adeno-associated virus type 2-mediated gene transfer: role of epidermal growth factor receptor protein tyrosine kinase in transgene expression

1 reference

12 December 2020

A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus

1 reference

12 December 2020

Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy

1 reference

12 December 2020

Adeno-associated virus-mediated delivery of erythropoietin leads to sustained elevation of hematocrit in nonhuman primates

1 reference

12 December 2020

Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer

1 reference

12 December 2020

Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors

1 reference

12 December 2020

Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors.

1 reference

12 December 2020

Adeno-associated viral vectors as gene delivery vehicles

1 reference

12 December 2020

Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

1 reference

12 December 2020

Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX.

1 reference

12 December 2020

Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue

1 reference

12 December 2020

Gene therapy vectors based on adeno-associated virus type 1.

1 reference

12 December 2020

Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization

1 reference

12 December 2020

Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression

1 reference

12 December 2020

Identifiers

DOI

10.1385/IR:26:1-3:247

1 reference

Dimensions Publication ID

5 August 2017

1040353391

0 references

1 reference